Showing results (511-520 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|December 2, 2017
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus CisplatinHyungwoo Cho, Changhoon Yoo, Kyu-Pyo Kim, et al.Investigational New Drugs|November 28, 2017
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trialEmiliano Calvo, Analia Azaro, Jordi Rodon, et al.Investigational New Drugs|October 31, 2017
Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancerLei Fang, Hao Wang, Peiling LiInvestigational New Drugs|September 8, 2017
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF V600 mutation-positive solid tumors: a phase 1 studyYutaka Fujiwara, Naoya Yamazaki, Yoshio Kiyohara, et al.Investigational New Drugs|September 19, 2017
Mechanisms of cancer cell killing by sea cucumber-derived compoundsTeresa Liliana Wargasetia, WidodoInvestigational New Drugs|September 22, 2017
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumorsNeeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, et al.Investigational New Drugs|September 3, 2017
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutationsKosei Hasegawa, Masahiro Kagabu, Mika Mizuno, et al.Investigational New Drugs|July 14, 2016
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemiaKaren W L Yee, Hsiao-Wei T Chen, David W Hedley, et al.Investigational New Drugs|April 1, 1989
The clinical syndrome of 5-fluorouracil cardiotoxicityJ F Ensley, B Patel, R Kloner, et al.Investigational New Drugs|April 1, 1989
Dynamic management of squamous cell cancer of the anal canalN D Nigro, V K Vaitkevicius, B ConsidinePageof 372